¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑôÃß±âÃÊ¿¬±¸È¸ Á¦13ȸ Á¤±âÇмú´ëȸ : 2022-09-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑôÃß±âÃÊ¿¬±¸È¸ Á¦13ȸ Á¤±âÇмú´ëȸ : 2022-09-03
±³À°ÀÏÀÚ : 2022-09-03
±³À°Àå¼Ò : »ïÁ¤È£ÅÚ º»°ü2Ãþ ¶óº¥´õBȦ  
±³À°ÁÖÁ¦ : ´ëÇÑôÃß±âÃÊ¿¬±¸È¸ Á¦13ȸ Á¤±âÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑôÃß±âÃÊ¿¬±¸È¸(´ëÇÑôÃ߽Űæ¿Ü°ú ±âÃÊ¿¬±¸È¸ 22.8.10 º¯°æ)  
´ã´çÀÚ : ¿À¿µ¹Ì
¿¬¶ôó : 02-2626-1178  
À̸ÞÀÏ : oym1977@hanmail.net      
±³À°Á¾·ù : ½Å°æ¿Ü°úÀÇ»çÇÐ, ÀÇÇб³À°
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í È¸¿ø ¹«·á, ºñȸ¿ø 5¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-03 »ïÁ¤È£ÅÚ º»°ü2Ãþ ¶óº¥´õBȦ 09:00~09:10 Treatment for Functional Recovery in Rat Spinal Cord Injury Model  ÇÑÀκ¸(Â÷ÀÇ°úÇÐ´ë ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-03 »ïÁ¤È£ÅÚ º»°ü2Ãþ ¶óº¥´õBȦ 09:10~09:20 The Osteogenic Effect of Human Mesenchyma Stem Cells in osteoporosis  ¹Ú¼º¹è(¼­¿ïÀÇ´ë ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-03 »ïÁ¤È£ÅÚ º»°ü2Ãþ ¶óº¥´õBȦ 09:20~09:30 The Gene Regulatory Network for skeletal Metastatsis in lung cancerr  ÇãÁؼ®(°í´ëÀÇ´ë ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-03 »ïÁ¤È£ÅÚ º»°ü2Ãþ ¶óº¥´õBȦ 09:30~09:40 Preclinical Study of Adult Human Multipotent Neural Cells for Rat Spinal Cord Injury model  ÇÔâȭ(°í´ëÀÇ´ë ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-03 »ïÁ¤È£ÅÚ º»°ü2Ãþ ¶óº¥´õBȦ 09:40~09:50 Modulation of cell regeneration with Mesenchymal Stem Cell for Acute Spinal Cord Injury  ±èÀϼ·(°¡Å縯ÀÇ´ë ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-03 »ïÁ¤È£ÅÚ º»°ü2Ãþ ¶óº¥´õBȦ 09:50~10:00 Effect of Simvastatin on th Nucleus Pulposus Cell: preclinical study  À±»óÈÆ(³ª´©¸®º´¿ø) 
±³À°½Ã°£ 09-03 »ïÁ¤È£ÅÚ º»°ü2Ãþ ¶óº¥´õBȦ 10:00~11:00 Targeting Class A GPCR Signaling Pathway for Hard Tissue Regeneration  ±èÁø¸¸(¼­¿ï´ë Ä¡ÀÇÇдëÇпø) 
±³À°½Ã°£ 09-03 »ïÁ¤È£ÅÚ º»°ü2Ãþ ¶óº¥´õBȦ 11:20~11:40 Primary Human Osteoblast and Osteoclast Culturing and Analysis  Á¶´ëö(°æºÏÀÇ´ë ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-03 »ïÁ¤È£ÅÚ º»°ü2Ãþ ¶óº¥´õBȦ 11:40~12:00 Technologies of BMP2 Activation forj Bone Formation: Exogenous and Endogenous  ¹Ú¼º¹è(¼­¿ïÀÇ´ë ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-03 »ïÁ¤È£ÅÚ º»°ü2Ãþ ¶óº¥´õBȦ 12:00~12:30 Role of Runx/Cbfb Complex in Skeletal Tissues  ÃÖÁ¦¿ë(°æºÏÀÇ´ë ¼¼Æ÷»ýÈ­Çб³½Ç) 
±³À°½Ã°£ 09-03 »ïÁ¤È£ÅÚ º»°ü2Ãþ ¶óº¥´õBȦ 13:40~14:40 3D Bioprinting Technology for Advanced Tissue Therapeutics  ÀåÁø¾Æ(Æ÷Ç×°ø´ë) 
±³À°½Ã°£ 09-03 »ïÁ¤È£ÅÚ º»°ü2Ãþ ¶óº¥´õBȦ 16:00~16:10 Spinal Parameter Measurement by machine learning (CNN and Deep learning)  ÀÌÁ¾¹ü(°¡Å縯ÀÇ´ë ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-03 »ïÁ¤È£ÅÚ º»°ü2Ãþ ¶óº¥´õBȦ 16:10~16:20 Safety and Efficacy of Modable and Compression Resistant Carrier Matrix with rhBMP-2 in osteoporosis Rat model  Çö½ÂÀç(¼­¿ïÀÇ´ë ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-03 »ïÁ¤È£ÅÚ º»°ü2Ãþ ¶óº¥´õBȦ 16:20~16:30 Osteogenic and Anti-inflammatory Effect of PLGA/ BMP-2/Mg(OH)2 Scaffold in a Mouse  ÀÌâ±Ô(°è¸íÀÇ´ë ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-03 »ïÁ¤È£ÅÚ º»°ü2Ãþ ¶óº¥´õBȦ 16:30~16:40 Carbon Nanoparticles Maintains Integrity of Blood Spinal Cord Barrier after Spinal Cord Injury in Rats  ÃÖ¿î¿ë(Â÷ÀÇ°úÇÐ´ë ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-03 »ïÁ¤È£ÅÚ º»°ü2Ãþ ¶óº¥´õBȦ 16:40~16:50 Chronic Hyperglycemia after Spinal Cord Injury Increases Inflammatory Reaction  ±è°æÅÂ(°æºÏÀÇ´ë ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-03 »ïÁ¤È£ÅÚ º»°ü2Ãþ ¶óº¥´õBȦ 16:50~17:00 Analysis of Proteome Method for Super-Resolution Imaging of Cell Which Retains Fluorescence  ¹ÚÁ¤À±(¿¬¼¼ÀÇ´ë ½Å°æ¿Ü°ú) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑôÃß±âÃÊ¿¬±¸È¸ Á¦13ȸ Á¤±âÇмú´ëȸ : 2022-09-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø ½ÉÀå³»°ú ¿Â¶óÀÎ ¿¬¼ö°­Á : 2022-09-03
´ÙÀ½±Û ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ, ´ëÇѳúÇ÷°ü³»Ä¡·áÀÇÇÐȸ ÇÕµ¿¿¬¼ö°­Á : 2022-09-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 105 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 5 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 5 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 5 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 1 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 1 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 1 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 1 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 1 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 1 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 1 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 1 2024-05-27
20880 ¼­¿ï (¿Â¶óÀÎ) 2024 ¸¶Æ÷±¸ÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
20879 ¼­¿ï Á¦10ȸ ¿ëºÀÀÇÇÐȸ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷